10-K Filing

Company

Ernexa Therapeutics Inc.

Filed

March 16, 2005

Period of Report

December 31, 2004

Accession Number

0001019687-05-000711

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →